Trial Profile

A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM)

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 20 Dec 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aceneuramic acid (Primary)
Indications Nonaka distal myopathy
Focus Therapeutic Use
Sponsors Nobelpharma

Most Recent Events

18 Dec 2017 Status changed from active, no longer recruiting to completed.
24 Aug 2016 Status changed from recruiting to active, no longer recruiting.
08 Aug 2016 Planned End Date changed from 31 Mar 2017 to 30 Sep 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com